These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 576939)

  • 1. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small cell bronchogenic carcinoma. A prolonged remission following chemotherapy.
    Cohen MH
    JAMA; 1977 Jun; 237(23):2528. PubMed ID: 576972
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
    Nagorni-Obradović L
    Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF; Weltz MD; Heim WJ; Blom J
    Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung].
    Karnicka-Młodkowska H; Jassem J; Mierzewski P; Słupek A; Mierzwa W; Decker E; Prokop A; Krawczyk K; Kowal E; Firlik M
    Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511
    [No Abstract]   [Full Text] [Related]  

  • 8. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.
    Chahinian AP; Mandel EM; Holland JF; Jaffrey IS; Teirstein AS
    Cancer; 1979 May; 43(5):1590-7. PubMed ID: 221093
    [No Abstract]   [Full Text] [Related]  

  • 9. Four-drug combination chemotherapy in advanced lung cancer: methotrexate, doxorubicin, cyclophosphamide and CCNU.
    Milstein D; Robinson E
    Cancer; 1981 Dec; 48(11):2358-63. PubMed ID: 7028245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
    Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
    Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive chemotherapy of small cell bronchogenic carcinoma.
    Cohen MH; Creaven PJ; Fossieck BE; Broder LE; Selawry OS; Johnston AV; Williams CL; Minna JD
    Cancer Treat Rep; 1977; 61(3):349-54. PubMed ID: 194691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.
    Cormier Y; Bergeron D; La Forge J; Lavandier M; Fournier M; Chenard J; Desmeules M
    Cancer; 1982 Sep; 50(5):845-9. PubMed ID: 7093924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of extensive large cell and adenocarcinoma of the lung: a randomized trial in 210 patients.
    Vincent RG; Mehta CR; Tucker RD; Mountain CF; Cohen M; Wilson HE; Vogel C
    Cancer; 1980 Jul; 46(2):256-60. PubMed ID: 6992978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP; Rosenbaum PR; Carbone PP
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
    Davis S; Pandya MR; Rambotti P
    Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.